BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22221260)

  • 1. Serotonin syndrome: SSRIs, SNRIs, triptans, and current clinical practice.
    Tepper SJ
    Headache; 2012 Feb; 52(2):195-7. PubMed ID: 22221260
    [No Abstract]   [Full Text] [Related]  

  • 2. Triptans, SSRIs/SNRIs and serotonin syndrome.
    Rothrock JF
    Headache; 2010 Jun; 50(6):1101-2. PubMed ID: 20618824
    [No Abstract]   [Full Text] [Related]  

  • 3. Triptans, serotonin agonists, and serotonin syndrome (serotonin toxicity): a review.
    Gillman PK
    Headache; 2010 Feb; 50(2):264-72. PubMed ID: 19925619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant use of triptan, and SSRI or SNRI after the US Food and Drug Administration alert on serotonin syndrome.
    Sclar DA; Robison LM; Castillo LV; Schmidt JM; Bowen KA; Oganov AM; Skaer TL; Kogut SJ
    Headache; 2012 Feb; 52(2):198-203. PubMed ID: 22289074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Coprescription of Triptan Antimigraine Drugs and Selective Serotonin Reuptake Inhibitor or Selective Norepinephrine Reuptake Inhibitor Antidepressants With Serotonin Syndrome.
    Orlova Y; Rizzoli P; Loder E
    JAMA Neurol; 2018 May; 75(5):566-572. PubMed ID: 29482205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The FDA alert on serotonin syndrome with use of triptans combined with selective serotonin reuptake inhibitors or selective serotonin-norepinephrine reuptake inhibitors: American Headache Society position paper.
    Evans RW; Tepper SJ; Shapiro RE; Sun-Edelstein C; Tietjen GE
    Headache; 2010 Jun; 50(6):1089-99. PubMed ID: 20618823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The FDA alert on serotonin syndrome with combined use of SSRIs or SNRIs and Triptans: an analysis of the 29 case reports.
    Evans RW
    MedGenMed; 2007 Sep; 9(3):48. PubMed ID: 18092054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant triptan and SSRI or SNRI use: what is the risk for serotonin syndrome?
    Evans RW
    Headache; 2008 Apr; 48(4):639-40. PubMed ID: 18377388
    [No Abstract]   [Full Text] [Related]  

  • 9. Triptans and serotonin syndrome.
    Evans RW
    Cephalalgia; 2008 May; 28(5):573-4; author reply 574-5. PubMed ID: 18355351
    [No Abstract]   [Full Text] [Related]  

  • 10. Careful scrutiny of the evidence for drug-drug interactions in clinical decision support systems is necessary.
    Horn JR; Hansten PD
    J Manag Care Pharm; 2011 Nov; 17(9):713. PubMed ID: 22050397
    [No Abstract]   [Full Text] [Related]  

  • 11. Serotonin syndrome and rhabdomyolysis induced by concomitant use of triptans, fluoxetine and hypericum.
    Bonetto N; Santelli L; Battistin L; Cagnin A
    Cephalalgia; 2007 Dec; 27(12):1421-3. PubMed ID: 17868285
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug interactions with triptans : which are clinically significant?
    Rolan PE
    CNS Drugs; 2012 Nov; 26(11):949-57. PubMed ID: 23018546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triptans and serotonin syndrome.
    Fine A; Bastings E
    Headache; 2012; 52(7):1184-5; author reply 1185-8. PubMed ID: 22755550
    [No Abstract]   [Full Text] [Related]  

  • 14. Serotonin Syndrome With the Concomitant Use of Triptans and SSRIs/Serotonergic Medications: Is It Time to Revisit FDA Warning?
    Mansuri Z; Adnan M; Shah B; Trivedi C; Vadukapuram R; Patel S; Yadav G; Srinivas S; Ansari M; Makani R; Baweja R; Reddy A
    J Clin Psychopharmacol; 2024 Mar-Apr 01; 44(2):199-200. PubMed ID: 38227629
    [No Abstract]   [Full Text] [Related]  

  • 15. Do triptan antimigraine medications interact with SSRI/SNRI antidepressants? What does your decision support system say?
    Kogut SJ
    J Manag Care Pharm; 2011 Sep; 17(7):547-51. PubMed ID: 21870895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin toxicity.
    Gillman K
    Headache; 2008 Apr; 48(4):640-1. PubMed ID: 18377389
    [No Abstract]   [Full Text] [Related]  

  • 17. The serotonin syndrome, triptans, and the potential for drug-drug interactions.
    Shapiro RE; Tepper SJ
    Headache; 2007 Feb; 47(2):266-9. PubMed ID: 17300366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Onset of Transient Sadness Following the Concomitant Use of a Triptan and Selective Serotonin Reuptake Inhibitor/Serotonin Norepinephrine Reuptake Inhibitors Therapy: A Case Report.
    Meng Y; Yuen J
    J Pharm Pract; 2023 Jun; 36(3):705-710. PubMed ID: 34962845
    [No Abstract]   [Full Text] [Related]  

  • 19. Serotonin syndrome and the use of SSRIs.
    Finfgeld DL
    J Psychosoc Nurs Ment Health Serv; 2004 Feb; 42(2):16-20. PubMed ID: 14982105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reassessing the contraindication of zolmitriptan and serotonin reuptake inhibitors: an evidence-based pharmacotherapeutic case report.
    Boutilier AS; Gardner DM
    J Clin Pharm Ther; 2003 Feb; 28(1):69-72. PubMed ID: 12605621
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.